NASDAQ:ANTH - Anthera Pharmaceuticals Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.10 +0.00 (+0.51 %)
(As of 03/20/2019 04:00 PM ET)
Previous Close$0.0990
Today's Range$0.09 - $0.10
52-Week Range$0.0070 - $0.3990
Volume5,801 shs
Average Volume55,917 shs
Market Capitalization$2.60 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy. The company has license agreements with Amgen, Inc., and Eli Lilly and Company. Anthera Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Hayward, California.

Receive ANTH News and Ratings via Email

Sign-up to receive the latest news and ratings for ANTH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:ANTH
CUSIPN/A
Phone510-856-5600

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Market Cap$2.60 million
Next Earnings Date3/25/2019 (Estimated)
OptionableOptionable

Anthera Pharmaceuticals (NASDAQ:ANTH) Frequently Asked Questions

What is Anthera Pharmaceuticals' stock symbol?

Anthera Pharmaceuticals trades on the NASDAQ under the ticker symbol "ANTH."

When did Anthera Pharmaceuticals' stock split? How did Anthera Pharmaceuticals' stock split work?

Shares of Anthera Pharmaceuticals reverse split on the morning of Monday, May 1st 2017. The 1-8 reverse split was announced on Friday, April 28th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Friday, April 28th 2017. An investor that had 100 shares of Anthera Pharmaceuticals stock prior to the reverse split would have 13 shares after the split.

How were Anthera Pharmaceuticals' earnings last quarter?

Anthera Pharmaceuticals Inc (NASDAQ:ANTH) announced its earnings results on Monday, March, 5th. The biopharmaceutical company reported ($0.73) EPS for the quarter, beating the consensus estimate of ($0.82) by $0.09. View Anthera Pharmaceuticals' Earnings History.

When is Anthera Pharmaceuticals' next earnings date?

Anthera Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Monday, March 25th 2019. View Earnings Estimates for Anthera Pharmaceuticals.

Has Anthera Pharmaceuticals been receiving favorable news coverage?

Media headlines about ANTH stock have trended positive on Wednesday, according to InfoTrie Sentiment. The research group identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Anthera Pharmaceuticals earned a media sentiment score of 2.3 on InfoTrie's scale. They also assigned media headlines about the biopharmaceutical company a news buzz of 6.0 out of 10, indicating that recent press coverage is somewhat likely to have an impact on the stock's share price in the near future.

Who are some of Anthera Pharmaceuticals' key competitors?

What other stocks do shareholders of Anthera Pharmaceuticals own?

Who are Anthera Pharmaceuticals' key executives?

Anthera Pharmaceuticals' management team includes the folowing people:
  • Mr. Paul F. Truex, Exec. Chairman (Age 49)
  • Mr. John Craig Thompson, Pres, CEO & Director (Age 51)
  • Dr. Renee Martin Ph.D., Sr. VP of Medical Sciences (Age 49)
  • Dr. William R. Shanahan Jr., M.D., J.D., Chief Medical Officer & Sr. VP (Age 69)
  • Ms. May Liu, Chief Accounting Officer, Sr. VP of Fin. & Admin. and Compliance Officer (Age 42)

How do I buy shares of Anthera Pharmaceuticals?

Shares of ANTH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Anthera Pharmaceuticals' stock price today?

One share of ANTH stock can currently be purchased for approximately $0.0995.

How big of a company is Anthera Pharmaceuticals?

Anthera Pharmaceuticals has a market capitalization of $2.60 million.

What is Anthera Pharmaceuticals' official website?

The official website for Anthera Pharmaceuticals is http://www.anthera.com.

How can I contact Anthera Pharmaceuticals?

Anthera Pharmaceuticals' mailing address is 25801 INDUSTRIAL BOULEVARD SUITE B, HAYWARD CA, 94545. The biopharmaceutical company can be reached via phone at 510-856-5600.


MarketBeat Community Rating for Anthera Pharmaceuticals (NASDAQ ANTH)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  300 (Vote Outperform)
Underperform Votes:  289 (Vote Underperform)
Total Votes:  589
MarketBeat's community ratings are surveys of what our community members think about Anthera Pharmaceuticals and other stocks. Vote "Outperform" if you believe ANTH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ANTH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/20/2019 by MarketBeat.com Staff

Featured Article: Put Option

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel